Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal

Adding boceprevir to PR was projected to reduce the number of liver complications and liver-related deaths, and to be cost effective in treating both previously untreated and treated patients. </AbstractSection> Copyright Springer International Publishing Switzerland 2013

MoreLess

Year of publication:	2013
Authors:	Elbasha, Elamin ; Chhatwal, Jagpreet ; Ferrante, Shannon ; Khoury, Antoine El ; Laires, Pedro
Published in:	Applied Health Economics and Health Policy. - Springer, ISSN 1175-5652. - Vol. 11.2013, 1, p. 65-78
Publisher:	Springer

More details

Extent:	text/html
Type of publication:	Article
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10011000744